Ophthalmologic Drug Guide

  • Douglas J. Rhee
  • Kathryn A. Colby
  • Christopher J. Rapuano
  • Lucia Sobrin

Table of contents

  1. Front Matter
    Pages i-xi
  2. Pages 33-39
  3. Pages 41-46
  4. Pages 47-54
  5. Pages 55-67
  6. Pages 69-72
  7. Pages 105-106
  8. Pages 107-120
  9. Back Matter
    Pages 121-142

About this book

Introduction

Ophthalmology has long been considered a surgical area because so many disorders/diseases are treated surgically rather than medically. In the past ten years, however, there have been considerable therapeutic breakthroughs in non-surgical treatments. For instance, anti-glaucoma agents have becoming increasingly effective. This edition will include a new chapter for retinal disease. There are now several pharmaceutical agents being used to treat these diseases. Specifically, age-related macular degeneration has many new products – macugen, lucentis, etc. – and intraocular infections are primarily treated with intravitreal medications. Additionally, the anti-allergy and dry eye markets have grown tremendously in the last 2-3 years (endura, restasis, xibrom, etc).

Keywords

drug eye formulary macular macular degeneration ophthalmology optometry pharmacologic therapy retina

Authors and affiliations

  • Douglas J. Rhee
    • 1
  • Kathryn A. Colby
    • 1
    • 2
  • Christopher J. Rapuano
    • 3
    • 4
  • Lucia Sobrin
    • 1
  1. 1.Harvard Medical SchoolMassachusetts Eye & Ear InfirmaryBostonUSA
  2. 2.Joint Clinical Research CenterMassachusetts Eye & Ear InfirmaryBostonUSA
  3. 3.Jefferson Medical CollegeWills Eye HospitalPhiladelphiaUSA
  4. 4.Cornea ServiceWills Eye HospitalPhiladelphiaUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-0-387-49964-2
  • Copyright Information Springer Science+Business Media, LLC 2007
  • Publisher Name Springer, New York, NY
  • eBook Packages Medicine
  • Print ISBN 978-0-387-33251-2
  • Online ISBN 978-0-387-49964-2
  • About this book